These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 3884766

  • 1. Inefficacy of immunosuppressive treatment in HBSAg-positive, delta-negative, moderate chronic active hepatitis in children.
    Vajro P, Orso G, D'Antonio A, Greco L, Fontanella A, Loffredo G, Oggero V, Buffolano W.
    J Pediatr Gastroenterol Nutr; 1985 Feb; 4(1):26-31. PubMed ID: 3884766
    [Abstract] [Full Text] [Related]

  • 2. Effect of immunosuppressive therapy on HBsAg-positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe.
    Sagnelli E, Piccinino F, Manzillo G, Felaco FM, Filippini P, Maio G, Pasquale G, Izzo CM.
    Hepatology; 1983 Feb; 3(5):690-5. PubMed ID: 6618436
    [Abstract] [Full Text] [Related]

  • 3. HBeAg/anti-HBe seroconversion during and after protracted immunosuppressive treatment in type B chronic hepatitis.
    Tanno H, Fay OH, Rojman JA, Palazzi J, Bessone F.
    J Med Virol; 1988 May; 25(1):45-51. PubMed ID: 3045258
    [Abstract] [Full Text] [Related]

  • 4. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
    Maier KP, Lepiorz H, Berthold H, Gerok W.
    Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
    [Abstract] [Full Text] [Related]

  • 5. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H, Fay O, Roldán L, Vorovioff J.
    Acta Gastroenterol Latinoam; 1982 Aug; 12(4):323-32. PubMed ID: 7185230
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive treatment of HBsAg-positive chronic liver disease: significance of HBeAg.
    Tage-Jensen U, Aldershvile J, Schlichting P.
    Hepatology; 1985 Aug; 5(1):47-9. PubMed ID: 3881331
    [Abstract] [Full Text] [Related]

  • 7. Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.
    Tolentino P, Jannuzzi C, Giacchino R.
    Infection; 1983 Aug; 11(5):255-9. PubMed ID: 6642677
    [Abstract] [Full Text] [Related]

  • 8. Treatment of HBsAg-positive chronic active hepatitis with corticosteroids and/or azathioprine. A prospective study.
    Manzillo G, Piccinino F, Sagnelli E, Izzo CM, Pasquale G, Maio G, Filippini P, Felaco FM.
    Ric Clin Lab; 1983 Aug; 13(2):261-8. PubMed ID: 6622929
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.
    Davis GL, Czaja AJ, Taswell HF, Ludwig J, Go VL.
    Dig Dis Sci; 1985 Feb; 30(2):97-103. PubMed ID: 3967568
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of adenine arabinoside and alpha-interferon in patients with HBeAg-positive chronic active hepatitis.
    Lee SU, Choi KH, Ha BJ, Suh SY, Han BH, Ku JY, Park BC.
    Korean J Intern Med; 1990 Jan; 5(1):1-4. PubMed ID: 2271507
    [Abstract] [Full Text] [Related]

  • 13. Treatment of chronic active hepatitis (CAH): a retrospective review of 130 patients.
    Giusti G, Ruggiero G, Galanti B, Piccinino F, Russo M, Galante D, Sagnelli E, Utili R, Pasquale G, Nardiello S, Aloisio V.
    Hepatogastroenterology; 1981 Oct; 28(5):245-9. PubMed ID: 7047337
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Treatment of chronic active hepatitis (HBsAg +,HBeAg +) with isoprinosine. Clinical evaluation].
    Cianciara J, Loch T, Babiuch L, Dabrowska-Bernstein B, Stasiak A, Dabrowski M, Pawińska A.
    Pol Tyg Lek; 1988 Sep 12; 43(37):1195-8. PubMed ID: 2470069
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of chronic active hepatitis--present state. The pros and cons of immunosuppressive therapy.
    Thaler H.
    Hepatogastroenterology; 1984 Feb 12; 31(1):6-11. PubMed ID: 6698488
    [Abstract] [Full Text] [Related]

  • 19. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
    Scullard GH, Smith CI, Merigan TC, Robinson WS, Gregory PB.
    Gastroenterology; 1981 Dec 12; 81(6):987-91. PubMed ID: 7286593
    [Abstract] [Full Text] [Related]

  • 20. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B.
    Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C.
    Hepatology; 1986 Dec 12; 6(6):1319-24. PubMed ID: 2431991
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.